Results 91 to 100 of about 10,533 (301)

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

Nekateri pristopi za izkoriščanje heteroze pri navadni pšenici (Triticum aestivum L.)

open access: yesActa Agriculturae Slovenica, 2011
Heterozo najpogosteje povezujemo s superiornostjo prve filialne generacije nad parentalno. Z gospodarskega stališča pa je še posebej pomembno, da se lahko ta superiornost izraža kot višji produktivni potencial sorte.
Primož TITAN, Vladimir MEGLIČ
doaj   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Public wireless Internet projects Wlan Slovenija and Otvorena mreža

open access: yes, 2020
Projekti wlan slovenija i Otvorena mreža su pokrenuti kako bi okupili zaljubljenike u tehnologiju te kombiniranim iskustvima i znanjima omogućili ljudima besplatan pristup Internetu bežičnim putem.
Lipošćak, Igor
core  

Regulatory harmonization: Evolution, globalization and future directions

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm   +2 more
wiley   +1 more source

Regular annual interview in RTV Slovenija [PDF]

open access: yes, 2012
Letni pogovori so del komunikacije med vodjo in sodelavcem. Gre za sistematično voden pogovor, kjer se vodja in sodelavec pogovarjata o stvareh, ki so pomembne za oba, a se o njih v vsakodnevni naglici običajno ne uspeta pogovoriti.
Lešnik, Nataša
core  

Implementation and use of risk minimization control tools in the EU: A multistakeholder survey

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study characterized stakeholders' experiences with national implementation of risk minimization control tools (RMCTs), such as healthcare professional qualification, healthcare facility accreditation and medical intervention prior to treatment initiation, for eight medicinal products across eight European Union countries. Methods We conducted
Sharon C. M. Essink   +21 more
wiley   +1 more source

Bronhiektazije: strokovne usmeritve za obravnavo na primarni, sekundarni in terciarni ravni

open access: yesZdravniški Vestnik
Bronhiektazije so kronična vnetna bolezen pljuč, za katero so značilne pridobljene trajne razširitve velikih bronhov ali bronhiolov. Spadajo med redkejše bolezni s prevalenco 67/100.000 prebivalcev.
Mitja Košnik   +23 more
doaj   +1 more source

Efficiency of the autonomous modular system in the implementation of the spray application process in the vineyard

open access: yesGlasnik Zaštite Bilja, 2022
Autonomous modular system mounted on a conventional (CON) sprayer operating on the principle of pulse-width modulation (PWM) control of electromagnetic valves represents state-of-the-art technology for implementation controlled application of spray ...
Peter Berk   +4 more
doaj  

Ceftriaxone‐associated immune haemolytic anaemia: A patient‐level systematic review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Ceftriaxone can cause acute haemolysis. Its clinical presentation, risk factors, and outcomes remain incompletely characterized. We conducted a systematic review of published cases with patient‐level data, following international guidelines and with registration in PROSPERO (CRD420261338709). Reports were identified through three bibliographic
Sonja Miotti   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy